SO-19 A multicenter phase Ⅱ trial of trifluridine/tipiracil in combination with cetuximab in RAS wild-type metastatic colorectal cancer patients refractory to prior anti-EGFR antibody therapy: The WJOG8916G trial
| Autor: | Masuishi, T., Izawa, N., Takahashi, N., Shoji, H., Yamamoto, Y., Matsumoto, T., Sugiyama, K., Kajiwara, T., Kawakami, K., Aomatsu, N., Kondoh, C., Kawakami, H., Takegawa, N., Esaki, T., Narita, Y., Hara, H., Sunakawa, Y., Boku, N., Moriwaki, T., Shimokawa, M., Nakajima, T., Muro, K. |
|---|---|
| Zdroj: | In Annals of Oncology July 2021 32 Supplement 3:S210-S211 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|